BOSTON--(BUSINESS WIRE)--Jun. 18, 2018--
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced the
opening of its new 170,000 square foot research facility in Torrey
Pines, San Diego. The new site represents a significant expansion of the
Company’s research presence in the area, and its continued investment in
the local economy. The San Diego site is one of Vertex’s three global
research hubs, and is where the Company’s three breakthrough cystic
fibrosis (CF) medicines were discovered.
“Our researchers in San Diego have spent the last 20 years doing what
was once thought impossible – developing the first medicines that treat
the underlying cause of cystic fibrosis,” said Dr. David Altshuler,
Executive Vice President, Global Research and Chief Scientific Officer.
“This team is a critical part of our global research effort, and the new
site will allow us to continue investing in science to bring more
transformative medicines to people with serious diseases.”
More than 70 percent of the new facility is dedicated to
state-of-the-art lab and research space. It features a 1,500 square foot
learning lab for science, technology, engineering, arts and math (STEAM)
education programs, expanding on the Company’s commitment to inspire and
equip the next generation of leaders in science; and a 4,000 square foot
incubator suite for external collaboration.
The new building, located at 3215 Merryfield Row, is LEED Gold certified
and is surrounded by two acres of dedicated outdoor space. Construction
of the new building was completed on schedule, in less than 18 months,
and was overseen by Alexandria Real Estate. Vertex has committed to a
16-year lease to fully occupy the site.
Vertex is a global biotechnology company that invests in scientific
innovation to create transformative medicines for people with serious
and life-threatening diseases. In addition to clinical development
programs in CF, Vertex has more than a dozen ongoing research programs
focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in Cambridge, Mass., Vertex's headquarters is now
located in Boston'sInnovation District. Today, the company has research
and development sites and commercial offices in the United States,
Europe, Canada and Australia. Vertex is consistently recognized as one
of the industry's top places to work, including being named to Science
magazine's Top Employers in the life sciences ranking for eight years in
For additional information and the latest updates from the company,
please visit www.vrtx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180618005794/en/
Source: Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Heather Nichols, 617-341-6992